Health minister Mark Butler has used question time to announce the 1 April expanded listing of Bristol Myers Squibb's immunotherapy OPDIVO (nivolumab).
Mark Butler goes early with confirmed expanded listing of BMS immunotherapy
March 30, 2023 Latest NewsBioPharma
Latest Video
New Stories
-
Priceline moves to stabilise banner group as pressures force administrators
December 17, 2025 - - Latest News -
Rare Cancers Australia gearing up for 2026 Kosi Challenge with Pharma Cup up for grabs again
December 17, 2025 - - Latest News -
Ferronova secures funding to advance nanoparticle technology for cancer surgery
December 17, 2025 - - Australian Biotech -
Antimalarial candidate under WEHI-MSD partnership offers fresh hope against resistance
December 17, 2025 - - Latest News -
OncoSil completes first production run at new Sydney manufacturing facility
December 17, 2025 - - Australian Biotech -
Budget update repeats the 'fiscal illusion' that has become PBS spending
December 17, 2025 - - Latest News -
Island Pharmaceuticals secures key partnership with Texas Biomed
December 17, 2025 - - Australian Biotech

